Life Sciences Report May 2020 – Procurement

Clinical Professionals and Vacancysoft

May 2020

For the pharmaceuticals industry, whilst the impact of the Covid19 crisis has yet to be seen, already questions are being asked about whether it makes sense to have outsourced manufacturing of medicines, as supply chains come under threat through export bans. As an example of this, the decision by the Government of India to ban the export of malaria drug hydroxychloroquine (HCQ), showed how fragile supply chains are. As another example, The MHRA now has
196 medicines which cannot be hoarded or exported from the UK – There were only 29 products on the list
at the beginning of 2020. The need to both secure both ingredients for manufacturing and with exports subject
to cross border restrictions has meant that this crisis has put pressure on procurement teams in a way not
seen before.

To find out more about the latest trends in the Procurement, download the report now!

Yes, I want this report!

    Yes, I would like to receive more information about your products, offers, and events. I understand I can unsubscribe at any time.*

    When you provide the information above, we will use it to process your request as described in our Privacy Policy .

    Related Posts

    Regulatory Implications for Insurance — UK Insuran... How are vacancies faring within the insurance sector in England and Wales? What is the impact of corporate governance jobs? Which regions are experien...
    Clinical — UK Life Sciences Labour Market Trends, ... How are scientific clinical vacancies faring in Europe’s life sciences industry? What are the leading sectors and roles? Which countries have the high...